首页> 美国卫生研究院文献>Orthopaedic Surgery >Use of a proximal humeral internal locking system enhanced by injectable graft for minimally invasive treatment of osteoporotic proximal humeral fractures in elderly patients
【2h】

Use of a proximal humeral internal locking system enhanced by injectable graft for minimally invasive treatment of osteoporotic proximal humeral fractures in elderly patients

机译:可注射移植物增强的肱骨近端内部锁定系统在微创治疗老年患者骨质疏松性肱骨近端骨折中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective:  To investigate the effect of treatment of osteoporotic proximal humeral fractures in elderly patients with a proximal humeral internal locking system (PHILOS) and minimally invasive injectable graft (MIIG). >Methods:  Patients who conformed to the inclusion criteria were randomly divided into two groups: group A (21 cases) were treated with PHILOS alone and group B (29 cases) were treated with PHILOS augmentation plus minimally invasive injectable graft (MIIG) X3 Hivisc. Postoperative follow‐up was performed regularly to check for complications, reduction loss and fracture healing by imaging. Shoulder joint function was scored and clinical results evaluated according to the Neer scoring system. >Results:  All patients were followed‐up and achieved fracture healing. The complication rate in group A (six cases) was greater than in group B (one case), the differences being statistically significant. The reduction loss in group A (2.9 ± 0.4 mm) was greater than in group B (1.5 ± 0.3 mm), this difference also being statistically significant. According to the Neer system, the excellent and good rate was 76.2% in group A and 82.8% in group B. >Conclusion:  PHILOS using MIPPO and augmented with MIIG X3 Hivisc produces satisfactory clinical results in aged patients with osteoporotic proximal humeral fractures and the method has advantages such as relatively minor trauma, stable fixation, fewer complications, and better joint function.
机译:>目的:研究采用肱骨近端内部锁定系统(PHILOS)和微创可注射移植物(MIIG)治疗老年患者骨质疏松性肱骨近端骨折的疗效。 >方法:将符合纳入标准的患者随机分为两组:A组(21例)单独接受PHILOS治疗,B组(29例)接受PHILOS增强联合微创注射治疗嫁接(MIIG)X3 Hivisc。定期进行术后随访,以通过影像检查检查并发症,复位减少和骨折愈合。根据Neer评分系统对肩关节功能进行评分并评估临床结果。 >结果:所有患者均得到随访,并实现了骨折愈合。 A组(6例)的并发症发生率高于B组(1例),差异有统计学意义。 A组(2.9±0.4 mm)的减少损失大于B组(1.5±0.3 mm)的减少损失,该差异也具有统计学意义。根据Neer系统,A组的优良率分别为76.2%和B组的82.8%。>结论: PHILOS联合MIPPO并加用MIIG X3 Hivisc在老年高脂血症患者中产生令人满意的临床效果骨质疏松性肱骨近端骨折及其方法具有创伤小,固定稳定,并发症少,关节功能好等优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号